Our deputy director, Prof. Prof. Chris Langmead, shared his thoughts on next generation treatments for #PTSD on abc730 this evening: abc.net.au/news/2022-11-0…

I may be less scientist and more desk jockey these days, but that doesn't mean that your work can't be enjoyable and impactful #BetterMedicines #BetterLives #Schizophrenia

Calling all post-doc level scientists wanting a career in industry with some of the best in immuno-oncology research: careersaustralia.monash.edu/cw/en/job/6441… We can't wait to meet you --> applications close December 11 🙏

Australia desperately needs to invest more money into discovery research Anthony Albanese Ed Husic MP. As a nation, we need to walk the talk. You can’t gut the engine room for innovation then demand more of it. And we can’t tolerate the systemic inequalities anymore Australian Research Council 👇🏾

Rebranding as Dr Spark

Delighted to speak with Sky News Australia about the TGA Australia decision to reschedule MDMA and psilocybin for the treatment of PTSD and resistant depression and ongoing work at Neuromedicines Discovery Centre Discovery Centre

⁦Neuromedicines Discovery Centre⁩ Discovery Centre is hiring a General Manager, Strategic Partnerships and Operations - be part of the development of next generation mental health therapeutics. #mentalhealth #medicines #drugdiscovery #strategy #operations linkedin.com/posts/chrislan…

Great line up of #speakers at the 2nd GPCR Targeted Drug Discovery Summit. Looking forward to learn from experts: BryanRoth, Prof. Chris Langmead @PhrenixTx, Jeff Finer @Septerna_Inc, just to mention a few! A #VR exploration of your #DrugTarget is mandatory bit.ly/3JI0k3R

Keen to study cancer cell plasticity and precision oncology? We are looking for an outstanding post-doc to work on an exciting and cutting-edge project at UniMelb Centre for Cancer Research and University of Melbourne, members of VCCC Alliance jobs.unimelb.edu.au/en/job/911751/…

New paper from a collaborative effort in delineating the role of GPR88 in motivational behaviour (and the surprising absence of striatal dopamine dysfunction) sciencedirect.com/science/articl…

To all of my followers. I need your help for people and their families who are dealing with Eating Disorders. Please sign this petition to help create pressure for funding. Also, share! We want 200k signatures! Community is power. aph.gov.au/e-petitions/pe…

Our The Conversation - Australia + New Zealand article on the pricing of psychedelic-assisted treatment for mental health disorders is out. Thanks to @neuromedicines and Monash University experts Prof. Prof. Chris Langmead, Prof. Cathy Mihalopoulos and Dr Mary Lou Chatteron. theconversation.com/the-tricky-eco…

Our Deputy Director, Prof. Prof. Chris Langmead, is looking forward to contributing to PSYCH symposium today on new medicines access in Australia #psychedelic #mentalhealth

Excited to be sharing the Neuromedicines Discovery Centre vision PSYCH British Museum #mentalhealth

📢 We’re looking for multiple PhD students on various projects requiring: 1. Background in ML, RL, active inference & neuroAI 2. Background in ML, time series analysis, MRI brain connectivity methods 3. Background in psychedelics, MRI & EEG data analysis Please RT 🙏

New on the Wall: "Sex-dependent attentional impairments in a subchronic ketamine mouse model for schizophrenia" by Daisy Spark, Ma, Nowell, Prof. Chris Langmead, Stewart & A/Prof Jess Nithianantharajah 🧠👩🏾‍🔬 🇱🇰🇦🇺 touchscreencognition.org/2023/07/19/sex…

Really excited to bring a Neuromedicines Discovery Centre and @PhrenixTx perspective to this @CGRS_Monash event!

Despite nearly half of Australians facing mental health conditions, treatment investment for this falls behind. Neuromedicines Discovery Centre, led by Prof. Chris Langmead, aims for evidence-based interventions, enhancing mental healthcare equity and efficiency. Read more: ​​monash.edu/pharm/about/ne…

The @PhrenixTx leadership team of Prof. Chris Langmead Greg Stewart and A/Prof Jess Nithianantharajah 🧠👩🏾‍🔬 🇱🇰🇦🇺 were delighted to be in NY and Boston for I Am Biotech Investor conference and other excellent meetings with the #VC community last week. Lots of interest in #CNS drug discovery and development.

This is the same in psychiatry; people think it can’t be done, it’s too hard. But it will remain forever insurmountable if we don’t try. This is why I work on Neuromedicines Discovery Centre and co-founded @PhrenixTx with Greg Stewart and A/Prof Jess Nithianantharajah 🧠👩🏾‍🔬 🇱🇰🇦🇺; because we can and must do better.